AS | Ankit Sarawagi|Founder, CFOmatrix·July 2026·11 min read | Fundraising |
- India does not use SAFEs. The SAFE is a US instrument. An Indian company raises through a convertible note, CCPS or CCDs instead.
- CCPS is the priced-round standard. Compulsorily Convertible Preference Shares carry preference rights and convert to Equity Shares; CCDs start as debt and convert.
- Priced round or convertible is a timing choice. A priced round sets the cap table now; a convertible defers the valuation with a cap and discount.
- Caps and discounts drive dilution. The valuation cap and discount set the price your early investor converts at, so set them deliberately.
- Keep it simple, limit the rights. Broad investor rights granted early (participating preferences, full-ratchet anti-dilution, long veto lists) bite hard at later rounds.
| 3 India instruments: note, CCPS, CCD (not SAFE) | 1x Non-participating liquidation preference is standard | 10-20% Typical convertible discount at the next round |
| 1. The instruments Indian SaaS uses 2. Why India does not use SAFEs 3. Priced round or convertible? | 4. Valuation cap and discount 5. The rights to watch 6. Keep it simple, limit the rights |
01The Instruments Indian SaaS Companies Use
Almost every early SaaS raise in India uses one of three fundraising instruments: a convertible note, Compulsorily Convertible Preference Shares (CCPS), or Compulsorily Convertible Debentures (CCDs). Which one you use depends on whether you are pricing the company now or deferring that decision to the next round. The fourth name founders hear, the US SAFE, belongs to a different legal system, and we will come to why in a moment.
The simplest way to hold them in your head: CCPS is the standard priced-round instrument, carrying preference rights and converting to Equity Shares; a convertible note or CCDs let you raise quickly now and convert to equity at the next priced round. All three eventually become Equity Shares, which is exactly what Indian foreign-investment rules require. For the wider fundraising picture, this post sits inside the SaaS finance pillar guide.
| Instrument | What it is | India or US | When used |
| Convertible note | A loan that converts to equity at the next round, usually with a cap and discount | India | Fast bridge raise without fixing a valuation now |
| CCPS | Preference shares that compulsorily convert to Equity Shares, with preference rights | India | The standard priced venture round (seed onward) |
| CCD | Debentures (debt) that compulsorily convert to Equity Shares, can carry interest | India | Bridge or debt-flavoured convertible financing |
| SAFE | A US agreement for future equity, no debt, no maturity | US only | Delaware or Singapore holdco, not the Indian entity |
02Why India Does Not Use SAFEs
The SAFE (Simple Agreement for Future Equity) was designed for Delaware companies: no interest, no maturity date, just a promise to issue shares at a future priced round. It is elegant for the US, and it is a poor fit for an Indian company. Indian company law and the foreign-investment rules expect money coming in to arrive as equity or as a compulsorily convertible instrument, CCPS or CCDs, with defined conversion terms and timelines. A SAFE, sitting as neither debt nor a recognised security, does not map onto that framework.
If you have flipped your holding company to the US or Singapore, a SAFE may be fine at that holdco level. But do not try to issue one from the Indian company, and do not let a foreign investor push a SAFE onto the Indian entity to save time. For the Indian entity the correct instruments are a convertible note, CCPS or CCDs. Confirm the right one for your exact structure with counsel before you sign.
This is also why the structure question and your instrument choice are linked: where your holding company sits decides which toolkit you can use. Get the structure right early and the instrument choice becomes clean; leave it messy and every raise turns into a legal puzzle.
03Priced Round or Convertible?
The first real decision is not which instrument, but whether to price the company now. A priced round issues CCPS at an agreed valuation and sets the cap table cleanly today. A convertible (a note or CCDs, with a valuation cap and discount) lets you raise fast and defer the valuation to the next round. Both are legitimate; the right answer depends on your traction and your appetite for pricing early.
- You have traction to support a valuation
- You want the cap table set cleanly now
- Investor wants preference rights from day one
- Slower and costlier to close, but final
- You want to raise quickly or bridge a round
- You would rather not price the company yet
- Cap and discount reward the early money
- Fast and cheap, but defers the dilution question
The trap with convertibles is that they feel free until they convert. Raise three notes at three different caps and, at the priced round, they all convert at once into a tangle of ownership you now have to reconcile. Model the conversion before you sign, keep the terms uniform, and read cap table and dilution alongside this so you can see the effect on ownership.
04Valuation Cap and Discount, in Plain Terms
A convertible converts into equity at the next priced round, and two terms decide the price the early investor pays when it does: the valuation cap and the discount. Both exist to reward an investor for backing you before the round that sets the price, and both directly drive how much you dilute at conversion.
A generous-sounding raise on a low valuation cap can dilute you more than a priced round would have, because the cap fixes how many shares the early money buys when it converts. Set the cap deliberately, not casually, and always model the conversion at your expected next-round valuation.
05The Rights to Watch
Beyond the price, an instrument carries rights, and this is where early generosity quietly costs you later. A handful of terms are standard and fair; a handful of variants are the ones to push back on. Here is the checklist to run through every term sheet.
06Keep It Simple, Limit the Rights
Whatever instrument you pick, the single most useful discipline is simplicity. An overcomplicated transaction, an unusual instrument, a bespoke conversion formula, a thicket of special rights, feels clever in the moment and becomes an anchor at the next round. Every future investor has to understand and inherit what you agreed before them, and complexity slows or sinks deals.
“Whenever you raise, keep the instrument simple and keep the rights you give investors limited. Do not overcomplicate the transaction, it becomes really hard to unwind at the later rounds, and I have seen broad investor rights bite founders very hard down the line.”
Ankit Sarawagi, from working across SaaS and AI SaaS startupsIn the AI SaaS companies I have worked with, hot rounds tempt founders to accept broad rights because the money is coming in fast and the valuation is flattering. That is exactly when to hold the line: a high valuation does not cancel out a full-ratchet clause or a heavy preference. Take the good price, keep the instrument plain, and limit the rights, because the round after this one is where those terms come due.
Simple economics fairly split, a clean instrument, and rights limited to real protection: that combination keeps every future raise faster and your ownership intact. To see how the instrument choice flows into the wider raise, read seed to Series A and valuation and ARR multiples, and model the ownership impact in cap table and dilution.
“The instrument you sign at seed is inherited by everyone who invests after. Keep it plain and keep the rights narrow, and you are doing your future self, and your future cap table, a favour.”
Ankit Sarawagi, CFOmatrix
|
FAQFrequently Asked Questions
What fundraising instruments do Indian startups use?
Indian startups typically raise through a priced equity round using Compulsorily Convertible Preference Shares (CCPS), or through a bridge instrument that converts later, most commonly a convertible note or Compulsorily Convertible Debentures (CCDs). CCPS is the standard instrument for a priced venture round because it gives investors preference rights while compulsorily converting to Equity Shares. Convertible notes and CCDs are used to raise quickly without fixing a valuation now. The US SAFE is not an Indian instrument and does not fit cleanly under Indian company and foreign-investment law, so Indian-incorporated companies use notes, CCPS or CCDs instead.
Can Indian startups use SAFE notes?
A SAFE (Simple Agreement for Future Equity) is a US instrument designed for Delaware companies. An Indian-incorporated company cannot cleanly issue a SAFE because it does not map to a recognised security under the Companies Act and the foreign-investment rules, which expect capital to come in as equity or as a compulsorily convertible instrument like CCPS or CCDs. Founders who have flipped their holding company to the US or Singapore may use SAFEs at the holdco level, but for the Indian entity the practical equivalents are a convertible note, CCPS or CCDs. Confirm the right instrument for your specific structure with your counsel before you sign.
What is the difference between CCPS and CCD?
Both are compulsorily convertible instruments that turn into Equity Shares, but CCPS (Compulsorily Convertible Preference Shares) is equity-like, while CCDs (Compulsorily Convertible Debentures) start as debt and convert. CCPS carries preference rights such as a liquidation preference and is the standard instrument for a priced venture round. CCDs sit as debt on the balance sheet until conversion, can carry interest, and are sometimes used for bridge financing. Both must convert to equity within the timelines set by Indian foreign-investment rules; they cannot stay unconverted or be redeemed for cash like ordinary debt or redeemable preference shares.
Should I raise a priced round or a convertible note?
Use a priced round (issuing CCPS at an agreed valuation) when you can support a valuation with real traction and want to set the cap table cleanly now. Use a convertible instrument (a convertible note or CCDs, with a valuation cap and discount) when you want to raise quickly, bridge to a larger round, or avoid pricing the company too early. Convertibles are faster and cheaper to close but defer the dilution question, and stacking several notes with different caps can create a messy cap table at conversion. Whichever you pick, keep the terms simple: an overcomplicated instrument today becomes very hard to unwind at the next round.
What is a valuation cap and a discount on a convertible?
A convertible note or CCD converts into equity at the next priced round, and the valuation cap and discount decide the price the early investor pays at conversion. The valuation cap is the maximum valuation at which their money converts, so if the next round prices the company higher, they still convert at the lower cap and get more shares for backing you early. The discount gives them a percentage reduction (commonly ten to twenty percent) off the next round’s price. Where both apply, the investor typically gets whichever is more favourable to them. Both reward early risk and both should be set deliberately because they directly drive how much you dilute at conversion.
Which investor rights should I limit in an early round?
Keep the economics fair but watch the rights that bite later. A liquidation preference of one times, non-participating, is standard; avoid participating or multiple preferences that pay the investor twice on an exit. On anti-dilution, broad-based weighted average is founder-reasonable; a full-ratchet clause can wipe out your ownership in a down round. Limit board seats and reserved matters (investor veto rights) to what an early investor genuinely needs, because a long list of consent items can freeze ordinary decisions. Give reasonable protection for the money, not control, and remember that broad rights granted early compound painfully by the time you reach a later, larger round.
This is general educational information for founders, current to mid-2026, drawing on the author’s experience across SaaS and AI SaaS startups, and is not legal, tax or investment advice. Instrument availability, conversion timelines and the treatment of convertible securities under the Companies Act and foreign-investment rules change and depend on your specific structure; verify the current position or consult qualified legal and tax counsel before issuing any instrument.
Seed to Series A: What Investors Test
Valuation and ARR Multiples
AS | Founder, CFOmatrix | Finance Strategy & Equity Compliance CFOmatrix is a knowledge platform focused on how finance actually works inside growing companies, from SaaS metrics and unit economics to structure, fundraising instruments and exits. |